Delivery Order SPE2DB20D2014-SPE2DB24FC99K

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Armour Thyroid 60 mg tablets. The contract has a firm fixed price of $1,591.56 and a period of performance through May 5, 2025. AmerisourceBergen, the prime contractor, is a for-profit organization headquartered in Conshohocken, Pennsylvania. The contract is not set-aside and was competitively awarded. As a large Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order with a ceiling value of $5,884.09. The contract is for the supply of Armour Thyroid 30 mg tablets in 100-count bottles. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 19, 2024. The contract is a firm fixed-price delivery order and does not have any set-aside designation, indicating open competition....
This is a $3,255.09 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Armour Thyroid 30 mg tablets. The contract has an ultimate completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a global pharmaceutical support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,163.57 firm-fixed-price contract is for the delivery of 4,567,866,841 units of Armour Thyroid 60 mg tablets by April 11, 2025. The contract is not set aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,275.59, is a Delivery Order for the supply of Armour Thyroid 30 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,023.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Armour Thyroid 30 mg Tablets in 100-count packages. The award has a ceiling value of $1,023.83 and an ultimate completion date of February 27, 2025. This contract is not designated as a set-aside and is an open competition award....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Armour Thyroid 90 mg tablets. The $17,270.97 firm-fixed-price contract has a performance period ending on September 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to procure a comprehensive range of pharmaceutical and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Armour Thyroid 90 mg tablets in 100-count bottles, with a total ceiling value of $8,573.86 and a period of performance through May 8, 2025. The contract is a firm-fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,130.12 firm fixed-price delivery order is for the supply of Armour Thyroid 90 mg tablets, with a performance period extending through May 12, 2025. The contract is not set aside for any small business designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,021.01 for the supply of Armour Thyroid 60 mg tablets. The contract is a firm-fixed-price delivery order placed by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract has an ultimate completion date of April 16, 2024 and does not have any set-aside designation, indicating the award was made through full and open competition....
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC99K
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,622.86 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of Armour Thyroid 60 mg tablets in 100-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by September 11, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to deliver critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical equipment, to various federal agencies and healthcare providers.

Generated 12/10/24, 2:31 PM